June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Investigation of MerTK intracellular tyrosine kinase residues used for RPE phagocytosis
Author Affiliations & Notes
  • Emeline F Nandrot
    Therapeutics, Institut de la Vision - UMR_S968, Paris, France
  • Dorine Neel
    Therapeutics, Institut de la Vision - UMR_S968, Paris, France
  • Ludovic Carduner
    Therapeutics, Institut de la Vision - UMR_S968, Paris, France
  • Eglantine Heude
    Therapeutics, Institut de la Vision - UMR_S968, Paris, France
  • Footnotes
    Commercial Relationships Emeline Nandrot, None; Dorine Neel, None; Ludovic Carduner, None; Eglantine Heude, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2317. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Emeline F Nandrot, Dorine Neel, Ludovic Carduner, Eglantine Heude; Investigation of MerTK intracellular tyrosine kinase residues used for RPE phagocytosis. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2317.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Mer tyrosine kinase (MerTK) receptors expressed at the apical surface of retinal pigment epithelial (RPE) cells are required to internalize shed photoreceptor outer segments tips (POS) following a circadian rhythm. MerTK defects lead to rod-cone dystrophies in human patients and to retinal phenotypes resembling retinitis pigmentosa in rodents. Some patients display fluorescence in their eye fundus, suggesting that phagocytosis is not completely absent. MerTK receptors are activated via tyrosine phosphorylation and display 17 tyrosine residues in their cytoplasmic tail. Therefore, we set out to characterize which of these amino acids are crucial for daily MerTK function.

Methods: We cloned rat and mouse MerTK cDNAs. We used site-directed mutagenesis to produce point mutations in each tyrosine residue of MerTK cytoplasmic tail, either constitutively inactivating or activating them. We transfected either the RPE-J cell line or MerTK-defective RPE cells from RCS rats in primary culture. We then challenged these cells with FITC-labeled POS to analyze effect of these mutations on their phagocytic capability and on MerTK activation.

Results: Constitutively inactivating some MerTK tyrosine residues decreases POS phagocytosis when compared to wild-type MerTK (e.g. Tyr544). In other cases, activating some MerTK tyrosines decreases POS phagocytosis while inactivating them increases phagocytosis (e.g. Tyr867). Alternatively, modifying the activity of some other tyrosines does not have any effect on POS phagocytosis (e.g. Tyr924).

Conclusions: The mutations tested had varioust effects on POS phagocytosis, either stimulating or inhibiting POS uptake. This suggests that MerTK tyrosines can carry different roles in daily POS elimination, that could be used at different times of day. In addition, it is possible that several tyrosine residues function simultaneously, as it has been shown for macrophages.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×